GIST Cancer Journal Spring Issue Out!
The 5th issue of the GIST Cancer Journal, official journal of the LRG and the first academic journal devoted solely to GIST is now available
Importance of Therapeutic Drug Monitoring for Targeted Therapies
As personalized medicine has become an accepted paradigm, it may be time for oncologists to examine personalized dose levels.In a recent article from Cancer World, the author explores the value of therapeutic drug monitoring for [...]
Side Effects of Targeted Treatments
The side effects of traditional chemotherapy treatments are often apparent, with images of bald patients with pain-etched faces captured in photographs. For targeted therapies such as those for GIST patients and other cancers that [...]
The Life Raft Group Joins OVAC
The Life Raft Group is pleased to announce its recent membership in One Voice Against Cancer (OVAC). Established in 2000, OVAC has grown to become the Capitol’s leading cancer coalition by unifying US cancer [...]
Blueprint Medicines Presents Preclinical Data on BLU-285
Blueprint Medicines presented new preclinical data on its drug candidate, BLU-285, and its potential value in treatment-resistant GIST and on novel cancer drug targets at the AACR (American Association for Cancer Research) Annual Meeting [...]
#ShowUsYourRare for GIST Awareness Day!
Last year’s inaugural GIST Awareness Day was a huge success, and we know with your help 2015 will be even bigger and better! This year, we’re celebrating GIST Awareness Day by creating a photo mosaic [...]
Jeff Davis: Fan of Miracle Comebacks
Jeff Davis - West Coast Florida Back in 1969 the New York Mets, a struggling team at the time, pulled off one of the most amazing comebacks in baseball. You could say [...]
Fatigue Reduction: Moving Towards a Better Future
As one of the most common side-effects of Gleevec, Sutent and Stivarga, fatigue is a condition that many GIST survivors are intimately acquainted with. The National Comprehensive Cancer Network defines cancer-related fatigue as “a [...]
Love is at the Heart of Henzo Kenya
As the Life Raft Group continues to grow globally, we will highlight our international friends in each newsletter issue. In this interview with Ferdinand Mwangura, Chairman of Henzo Kenya, we discover how the seeds [...]
Study Indicates Use Of Adjuvant Imatinib Therapy For GIST Increasing
A recent study published in the American Journal of Clinical Oncology found that the use of adjuvant systemic therapy with imatinib for GIST has increased significantly over time, and that patients treated with the therapy [...]